Maraganore, Meanwell Launch Corsera, Their Third Act In Cardiovascular Disease

Start-Up Has Predictive Test, Once-Yearly RNAi Drug

 
• By Mandy Jackson
  
Corsera's cardiovascular risk prediction tool pairs AI with genetic and other patient data (Shutterstock)

More from Start-Ups & SMEs

More from Business